Table 4.
-----Pregnancy---- | -----Postpartum---- | -----Postpartum---- | ||||
---|---|---|---|---|---|---|
15 weeks | 59 weeks | 59 weeks | ||||
‡β (SE) | p-value | ‡β (SE) | p-value | †r | p-value | |
DBP (mm Hg) | 0.775 (0.796) | 0.3330 | 0.089 (0.568) | 0.8761 | −0.10 | 0.4151 |
SBP (mm Hg) | 1.022 (1.073) | 0.3433 | 1.011 (0.969) | 0.3011 | −0.06 | 0.5938 |
Triglycerides (mg/dL) | 14.396 (4.415) | 0.0016 | 11.769 (6.124) | 0.0596 | 0.41 | 0.0003 |
Chol (mg/dL) | 3.971 (3.986) | 0.3219 | −0.872 (3.411) | 0.7992 | 0.20 | 0.0912 |
HDL (mg/dL) | −2.775 (1.966) | 0.1618 | −3.209 (1.328) | 0.0189 | −0.26 | 0.0280 |
CHOL/HDL (ratio) | 0.183 (0.082) | 0.0279 | 0.159 (0.084) | 0.0625 | 0.37 | 0.0012 |
Friedewalk LDL Chol (mg/dL) | 3.889 (3.433) | 0.2604 | 0.205 (2.898) | 0.9439 | 0.28 | 0.0151 |
Insulin (uU/mL) | 1.962 (0.570) | 0.0009 | 0.495 (0.726) | 0.4978 | 0.32 | 0.0051 |
Glucose (mg/dL) | 1.933 (0.860) | 0.0272 | 0.494 (1.075) | 0.6475 | 0.29 | 0.0116 |
HOMA-IR | 9.404 (2.719) | 0.0008 | 2.910 (3.387) | 0.3939 | 0.36 | 0.0017 |
C-Peptide (ng/mL) | 0.223 (0.046) | 0.0001 | 0.074 (0.078) | 0.3507 | 0.52 | 0.0001 |
Glycated serum protein (umol/L) | - | - | −3.487 (4.184) | 0.4079 | −0.34 | 0.0033 |
Glycated albumin (%) | - | - | −0.159 (0.150) | 0.2947 | −0.38 | 0.0010 |
Albumin (g/dL) | - | - | 0.003 (0.027) | 0.9187 | −0.03 | 0.8004 |
Leptin (ug/L) | 3.640 (1.928) | 0.0624 | 8.777 (4.273) | 0.0446 | 0.40 | 0.0005 |
Adiponectin HMW (mg/dL) | −543.58 (278.91) | 0.0546 | −195.96 (222.21) | 0.3815 | −0.17 | 0.1539 |
TNF-α (pg/mL) | 0.099 | 0.0526 | - | - | - | - |
IL-6 (pg/mL) | 0.34 | 0.0014 | - | - | - | - |
Regression model included VAT (kg), baseline metabolic variable, group, ethnicity, baseline age, baseline weight, baseline BMI, and weeks postpartum. GDM was an additional covariate for the 59 week regression models. Statistically significant p-values are in bold.
Spearman correlations between VAT (kg) and cardiometabolic risk factors at 59 weeks postpartum